Comments
Loading...
CRISPR Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CRSP | Benzinga
CRISPR Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-1.380
Quarterly Revenue Estimate
$10.54M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$35.00M
Analyze the earnings history of CRISPR Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics | -$1.43 | -$1.38 | — | — | $504.00K | $10.54M | — | — | 05/07/2025 | Get Alert |
| CRSP | CRISPR Therapeutics | $1.10 | -$1.21 | -$0.44 | 63.64% | $201.21M | $7.38M | $35.69M | 383.62% | 02/11/2025 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.41 | -$1.42 | -$1.01 | 28.87% | $0.00 | $6.81M | $602.00K | -91.16% | 11/05/2024 | Get Alert |
| CRSP | CRISPR Therapeutics | -$0.98 | -$1.52 | -$1.49 | 1.97% | $70.00M | $3.54M | $517.00K | -85.40% | 08/05/2024 | Get Alert |
| CRSP | CRISPR Therapeutics | -$0.67 | -$1.42 | -$1.43 | -0.70% | $100.00M | $28.11M | $504.00K | -98.21% | 05/08/2024 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.41 | -$0.07 | $1.10 | 1671.43% | $6.00K | $131.63M | $201.21M | 52.86% | 02/21/2024 | Get Alert |
| CRSP | CRISPR Therapeutics | -$2.24 | -$1.96 | -$1.41 | 28.06% | $94.00K | $8.43M | $0.00 | -100.00% | 11/06/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$2.40 | -$2.12 | -$0.98 | 53.77% | $158.00K | $1.71M | $70.00M | 3993.57% | 08/07/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$2.32 | -$1.70 | -$0.67 | 60.59% | $940.00K | $22.98M | $100.00M | 335.16% | 05/08/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.84 | -$2.30 | -$1.41 | 38.70% | $12.90M | $7.12M | $6.00K | -99.92% | 02/21/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.67 | -$2.29 | -$2.24 | 2.18% | $824.00K | $1.62M | $94.00K | -94.20% | 11/01/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | $9.44 | -$2.23 | -$2.40 | -7.62% | $900.70M | $2.06M | $158.00K | -92.33% | 08/08/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.51 | — | -$2.32 | — | $539.00K | — | $940.00K | — | 05/09/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.50 | -$1.77 | -$1.84 | -3.95% | $370.00K | $2.27M | $12.90M | 468.24% | 02/15/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.32 | -$1.76 | -$1.67 | 5.11% | $148.00K | $1.12M | $824.00K | -26.43% | 11/03/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.30 | $3.52 | $9.44 | 168.18% | $44.00K | $420.92M | $900.70M | 113.98% | 07/29/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.15 | -$1.47 | -$1.51 | -2.72% | $157.00K | $1.14M | $539.00K | — | 04/27/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | $0.51 | -$1.27 | -$1.50 | -18.11% | $77.02M | $2.32M | $370.00K | -84.05% | 02/16/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | $2.40 | -$1.18 | -$1.32 | -11.86% | $211.93M | $2.06M | $148.00K | -92.82% | 10/28/2020 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.01 | -$0.95 | -$1.30 | -36.84% | $318.00K | $18.12M | $44.00K | -99.76% | 07/27/2020 | Get Alert |
| CRSP | CRISPR Therapeutics | -$0.93 | — | -$1.15 | — | $328.00K | — | $157.00K | — | 04/28/2020 | Get Alert |
CRISPR Therapeutics (CRSP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-11 | $-0.44 | $-1.21 | 63.6 % |
| Q3 | 2024-11-05 | $-1.01 | $-1.42 | 28.9 % |
| Q2 | 2024-08-05 | $-1.49 | $-1.52 | 1.97 % |
| Q1 | 2024-05-08 | $-1.43 | $-1.42 | -0.70 % |
CRISPR Therapeutics (CRSP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-11 | $35.69M | $7.38M | 383.6 % |
| Q3 | 2024-11-05 | $602.00K | $6.81M | -91.2 % |
| Q2 | 2024-08-05 | $517.00K | $3.54M | -85.4 % |
| Q1 | 2024-05-08 | $504.00K | $28.11M | -98.2 % |
FAQ
When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?
CRISPR Therapeutics (CRSP) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 11, 2025 for Q4.
What were the latest earnings per share (EPS) for CRISPR Therapeutics (NASDAQ:CRSP)?
The Actual EPS was $-0.44, which beat the estimate of $-1.21.
What were CRISPR Therapeutics’s (NASDAQ:CRSP) revenues?
The Actual Revenue was $35.7M, which beat the estimate of $7.4M.
Browse earnings estimates, EPS, and revenue on all stocks.